A case of adenomyosis with leiomyoma that was effectively treated with relugolix and kamishoyosan add-on therapy
Abstract Background Recently, relugolix, an oral gonadotropin-releasing hormone receptor antagonist, has been considered an effective therapy for leiomyoma based on a phase 3 study in Japanese women. Leiomyoma combined with severe adenomyosis occasionally occurs in perimenopausal women; however, lit...
Saved in:
Main Authors: | Yukifumi Sasamori (Author), Kohei Takehara (Author), Tsuyoshi Terashima (Author), Takako Onodera (Author), Keita Yatsuki (Author), Ippei Nakagawa (Author), Yuko Takahashi (Author), Haruka Nishida (Author), Takayuki Ichinose (Author), Haruko Hiraike (Author), Kazunori Nagasaka (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapid reduction of adenomyosis coexisting with leiomyoma volume during treatment with Relugolix
by: Keitaro Yamanaka, et al.
Published: (2023) -
Serum vascular endothelial growth factor associated with the progression of granulosa cell tumor: a report of two cases
by: Kazuki Takasaki, et al.
Published: (2023) -
Prognostic analysis of peritoneal washing cytology during interval debulking surgery in advanced ovarian cancer
by: Kazuki Takasaki, et al.
Published: (2024) -
Kamishoyosan reduces conditioned fear-induced freezing behavior in socially isolated ovariectomized rats
by: Nobuaki Egashira, et al.
Published: (2016) -
A case of lichenoid drug eruption associated with relugolix
by: Joseph Han, BS, et al.
Published: (2023)